Literature DB >> 7140725

Assays of the heme biosynthetic enzymes. Preface.

D F Bishop, R J Desnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7140725

Source DB:  PubMed          Journal:  Enzyme        ISSN： 0013-9432


× No keyword cloud information.
  5 in total

1.  Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.

Authors:  J R Garey; L M Harrison; K F Franklin; K M Metcalf; E S Radisky; J P Kushner
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.

Authors:  David F Bishop; Annika Johansson; Robert Phelps; Amr A Shady; Maria C M Ramirez; Makiko Yasuda; Andres Caro; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2006-02-09       Impact factor: 11.025

3.  RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Senkottuvelan Kadirvel; Chunli Yu; John D Phillips; Maria I New; Abigail Liebow; Kevin Fitzgerald; William Querbes; Robert J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

4.  Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.

Authors:  P Hinnen; F W de Rooij; E M Terlouw; A Edixhoven; H van Dekken; R van Hillegersberg; H W Tilanus; J H Wilson; P D Siersema
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

5.  Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.

Authors:  Amy Chan; Abigail Liebow; Makiko Yasuda; Lin Gan; Tim Racie; Martin Maier; Satya Kuchimanchi; Don Foster; Stuart Milstein; Klaus Charisse; Alfica Sehgal; Muthiah Manoharan; Rachel Meyers; Kevin Fitzgerald; Amy Simon; Robert J Desnick; William Querbes
Journal:  Mol Ther Nucleic Acids       Date:  2015-11-03       Impact factor: 10.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.